Evidence map›Paper›PMID 29905915›Full record

ReviewCurrent HIV/AIDS reports2018

Network Research Experiences in New York and Eastern Europe: Lessons for the Southern US in Understanding HIV Transmission Dynamics.

Samuel R Friedman, Leslie Williams, April M Young, Jennifer Teubl, Dimitrios Paraskevis, Evangelia Kostaki, Carl Latkin, Danielle German, Pedro Mateu-Gelabert, Honoria Guarino and 6 more

Open access · greenAbstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 5 countries.

Samuel R FriedmanNational Development and Research Institutes, Inc., New York, NY, USA. friedman@ndri.org.
Leslie WilliamsNational Development and Research Institutes, Inc., New York, NY, USA.
April M YoungDepartment of Epidemiology, University of Kentucky College of Public Health, Lexington, KY, USA.
Jennifer TeublNational Development and Research Institutes, Inc., New York, NY, USA.
Dimitrios ParaskevisDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Evangelia KostakiDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Carl LatkinDepartment of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Danielle GermanDepartment of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Pedro Mateu-GelabertNational Development and Research Institutes, Inc., New York, NY, USA.
Honoria GuarinoNational Development and Research Institutes, Inc., New York, NY, USA.
Tetyana I VasylyevaDepartment of Zoology, University of Oxford, Oxford, UK.
Britt SkaathunDivision of Global Public Health, University of California San Diego, San Diego, CA, USA.
John SchneiderDepartment of Medicine and Center for HIV Elimination, University of Chicago, Chicago, IL, USA.
Ania KorobchukAlliance for Public Health, Kyiv, Ukraine.
Pavlo SmyrnovAlliance for Public Health, Kyiv, Ukraine.
Georgios NikolopoulosMedical School, University of Cyprus, Nicosia, Cyprus.
National Development and Research Institutes · USAlliance for Public Health · UAJohns Hopkins University · USNational and Kapodistrian University of Athens · GRUniversity of California, San Diego · USUniversity of Chicago · USUniversity of Cyprus · CYUniversity of Kentucky · USUniversity of Oxford · GB

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
HOPE Training GrantT32AI007384 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sara Gianella Weibel, Scott L Letendre · 1990 to 2026
$9.7M
Examining the Impact of the Twin Epidemics of Methamphetamine and Opioid Use on Overdose, Risky Sex and Treatment Engagement among PWUD in Two Rural Appalachian CohortsR01DA033862 · NIDA · UNIVERSITY OF KENTUCKY · PI Jennifer R Havens · 2012 to 2026
$6.9M
Preventing HIV Transmission by Recently-Infected Drug UsersDP1DA034989 · NIDA · NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC. · PI FRIEDMAN, SAMUEL R · 2012 to 2016
$3.8M
HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription OpioidsR01DA035146 · NIDA · NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC. · PI MATEU-GELABERT, PEDRO · 2013 to 2017
$2.9M
Social networks and HIV risk among rural drug usersR01DA024598 · NIDA · UNIVERSITY OF KENTUCKY · PI HAVENS, JENNIFER R · 2008 to 2012
$2.6M
Accelerating PrEP Diffusion through Network Change AgentsR01AI120700 · NIAID · UNIVERSITY OF CHICAGO · PI SCHNEIDER, JOHN · 2015 to 2019
$2.2M
Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)UG3DA044829 · NIDA · UNIVERSITY OF CHICAGO · PI JENKINS, WILEY, PHO, MAI TUYET · 2017 to 2018
$1.1M
Social networks, social resources, and HIV transmissionK01DA041259 · NIDA · JOHNS HOPKINS UNIVERSITY · PI GERMAN, DANIELLE · 2016 to 2020
$829k
NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI120700NIAID NIH HHS T32 AI007384NIDA NIH HHS DP1 DA034989NIDA NIH HHS K01 DA041259NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA024598NIDA NIH HHS R01 DA033862NIDA NIH HHS R01 DA035146NIDA NIH HHS UG3 DA044829
6 · The paper itself

Abstract

purposeThis paper presents an overview of different kinds of risk and social network methods and the kinds of research questions each can address. RECENT

findingsIt also reviews what network research has discovered about how network characteristics are associated with HIV and other infections, risk behaviors, preventive behaviors, and care, and discusses some ways in which network-based public health interventions have been conducted. Based on this, risk and social network research and interventions seem both feasible and valuable for addressing the many public health and social problems raised by the widespread use of opioids in the US South.

Indexed as

Risk-TakingSocial SupportAdultEurope, EasternFemaleHIVHIV InfectionsHumansMaleNew YorkOpioid-Related DisordersRiskBehaviorsHIVOpioid usersPhylogeneticsPWUDQuasi-networksRespondent-driven samplingRisk networksSocial networks

Identifiers

PMID29905915
PMCPMC6010197
OpenAlexW2805205030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.